|
| Monday, 30 September 2013, 11:00 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
|
| A*STAR's new Nanoimprint Foundry will bridge the gap between laboratory-based nanotechnologies and real-world products. This is the first time that Singapore nanotechnology suppliers and manufacturers have been brought together to speed up productisation of nanoimprinting, a technology that imbues ordinary surfaces with unique properties for applications in sectors like consumer care, biomedical devices, optics, filtration, displays and maritime. |
SINGAPORE, Sept 30, 2013 - (ACN Newswire) - Adhesives that leave no sticky residue, 'skins' that keep medical instruments germ-free, new anti-reflective protectors for displays or surfaces that prevent barnacles from attaching to ships. These are just some of the products that nanoimprinting technology is capable of producing. A*STAR's Institute of Materials Research and Engineering (IMRE) and its partners launched a new Nanoimprint Foundry that will develop, test-bed and prototype specially engineered plastics and surfaces for the specific purpose of commercialising the technologies. Possible applications of nanoimprint technology include dry adhesives, aesthetic packaging, contact lenses, biomedical cell scaffolds, anti-frost surfaces and anti-bacteria materials.
The multi-party investment will bring together national research organisations, suppliers and manufacturers spanning the nanotechnology value chain, and government agencies to promote the technology. The Foundry is part of a masterplan spearheaded by A*STAR to push translational research and accelerate commercialisation of home-grown technologies. In partnership with other A*STAR research institutes, IMRE will work with companies like Toshiba Machines Co Ltd, EV Group, NTT Advanced Technology Corporation, NIL Technology ApS, Kyodo International Inc., micro resist technology GmbH, Nanoveu Pte Ltd and Solves Innovative Technology Pte Ltd to produce prototypes for real-world products and applications. The Foundry and its partners will also work closely with Singapore's Economic Development Board (EDB) and SPRING to promote its nanoimprint applications to industry as part of the plans to build up Singapore's high-value manufacturing capabilities.
"We can help companies develop up to 20,000 samples for proof-of-concept and pilot production allowing manufacturers to shorten the product cycle but minus the heavy capital R&D investment", said Dr Karen Chong, the IMRE scientist who is heading the Foundry. Dr Chong added that the Foundry will be a one-stop shop for companies seeking to conceive, design and develop solutions for new, revolutionary products based on the versatile nanoimprint technology.
"The Foundry gives us the tools for creating real products that target industry end users and ultimately consumers", explained Mr Masayuki Yagi, Director & General Manager, Advanced Machinery Business Unit, Toshiba Machines Co Ltd, Japan on why the company chose to participate in the initiative. "Toshiba Machines and the Foundry will aim to deliver innovative engineering solutions based on nanoimprint and be the best partner for leading industries.
According to Mr Koh Teng Kwee, Director of Solves Innovative Technology Pte Ltd, "Working with IMRE since ICON 1 , I am sure IMRE's nanoimprint technology and know-how is now ready for industrial adoption. In my opinion, IMRE is able to provide everything needed for a new product realisation involving nanoimprinting."
"There is a billion-dollar, virtually untapped market for new advanced nanotechnology products that can make use of what the Foundry has to offer", said Prof Andy Hor, Executive Director for IMRE, adding that the initiative will hasten the industrialisation of nanoimprinting in this lucrative market segment. In consumer care for example, the global market for contact lenses - where nanoimprint technology can be used to produce new functionalities like multi-coloured lenses - is expected to grow to USD 11.7 billion by 2015 .
"The Foundry is the first one-stop shop to pull different value chain partners together to offer solutions based on nanoimprint through equipment, moulds, materials and applications to end user companies", said Dr Tan Geok Leng, Executive Director of A*STAR's Science and Engineering Research Council which oversees a number of the research institutes dedicated to the physical sciences and engineering. "The new Foundry is part of Singapore's strategy to create a new, advanced high-value manufacturing sector to support its growing knowledge-based economy."
"As part of EDB's vision to position Singapore as an Advanced Manufacturing Hub, we will continue to work with companies to co-create and adopt advanced manufacturing technologies. We see this new Research Foundry as one of the key infrastructures to strengthen nanoscale-manufacturing capabilities in Singapore", said Mr Yi-Hsen Gian, Director (i3), Economic Development Board (EDB), Singapore.
The Foundry was launched on 30 September 2013 during a ceremony that also saw collaboration agreements signed between A*STAR and its industry partners.
1) Industrial Consortium On Nanoimprint, Project 1 on anti-reflection surfaces
2) Global Industry Analysts, Inc.
About A*STAR's Nanoimprint Foundry
A*STAR's Nanoimprint Foundry is an R&D based nanoimprint foundry dedicated to driving the applications and industrial adoption of nanoimprint as a transformative technology across multiple industry sectors. The Foundry is a co-development between Science and Engineering Research Council (SERC), Institute of Materials Research and Engineering (IMRE) and also Exploit Technologies Pte Ltd (ETPL) of the Agency for Science Technology and Research (A*STAR), with the participation of other multi-disciplinary A*STAR institutes and industry collaborators to enable the evolution of nanoimprint technology from the laboratory to the manufacturing floor.
The Foundry has capabilities to address both prototype and high throughput nanoimprinting:
- Roll-to-roll, batch and wafer manufacturing capabilities
- Resolution achieved via roll-to-roll nanoimprinting = 50 nm
- Production speed of more than 30m per minute
About the Institute of Materials Research and Engineering (IMRE)
The Institute of Materials Research and Engineering (IMRE) is a research institute of the Agency for Science, Technology and Research (A*STAR). The Institute has capabilities in materials analysis & characterisation, design & growth, patterning & fabrication, and synthesis & integration. We house a range of state-of-the-art equipment for materials research including development, processing and characterisation. IMRE conducts a wide range of research, which includes novel materials for sensors & Transducers, consumer care, organic solar cells, photovoltaics, printed electronics, catalysis, bio-mimetics, microfluidics, quantum dots, heterostructures, sustainable materials, atom technology, etc. We collaborate actively with other research institutes, universities, public bodies, and a wide spectrum of industrial companies, both globally and locally. For more information about IMRE, please visit www.imre.a-star.edu.sg.
Contact:
Mr Eugene Low
Manager, Corporate Communications
Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8491
Mobile: +65 9230 9235
Email: loweom@scei.a-star.edu.sg
For technical enquiries, contact:
Dr Karen Chong
Scientist III, Institute of Materials Research and Engineering (IMRE)
DID: +65 6874 8426
E-mail: karen-chong@imre.a-star.edu.sg
Topic: New Service
Source: A*STAR
Sectors: Design Process, Daily Finance, Engineering, Chemicals, Spec.Chem, Science & Nanotech, Science & Research
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
